-
2
-
-
4444262374
-
The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging
-
DOI 10.1523/JNEUROSCI.1796-04.2004
-
Navakkode S, Sajikumar S, Frey JU (2004) The type IV-specific phosphodiesterase inhibitor rolipram and its effect on hippocampal long-term potentiation and synaptic tagging. J Neurosci 24: 7740-7744. (Pubitemid 39186829)
-
(2004)
Journal of Neuroscience
, vol.24
, Issue.35
, pp. 7740-7744
-
-
Navakkode, S.1
Sajikumar, S.2
Frey, J.U.3
-
3
-
-
54849409586
-
Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum
-
Nishi A, Kuroiwa M, Miller DB, O'Callaghan JP, Bateup HS, et al. (2008) Distinct roles of PDE4 and PDE10A in the regulation of cAMP/PKA signaling in the striatum. J Neurosci 28: 10460-10471.
-
(2008)
J Neurosci
, vol.28
, pp. 10460-10471
-
-
Nishi, A.1
Kuroiwa, M.2
Miller, D.B.3
O'Callaghan, J.P.4
Bateup, H.S.5
-
4
-
-
12844277227
-
Glutamate regulation of DARPP-32 phosphorylation neostriatal neurons involves activation of multiple signaling cascades
-
DOI 10.1073/pnas.0409138102
-
Nishi A, Watanabe Y, Higashi H, Tanaka M, Nairn AC, et al. (2005) Glutamate regulation of DARPP-32 phosphorylation in neostriatal neurons involves activation of multiple signaling cascades. Proc Natl Acad Sci U S A 102: 1199-1204. (Pubitemid 40170749)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.4
, pp. 1199-1204
-
-
Nishi, A.1
Watanabe, Y.2
Higashi, H.3
Tanaka, M.4
Nairn, A.C.5
Greengard, P.6
-
5
-
-
84885174946
-
The role of phosphodiesterases in hippocampal synaptic plasticity
-
Sanderson TM, Sher E (2013) The role of phosphodiesterases in hippocampal synaptic plasticity. Neuropharmacology 74: 86-95.
-
(2013)
Neuropharmacology
, vol.74
, pp. 86-95
-
-
Sanderson, T.M.1
Sher, E.2
-
6
-
-
77955374442
-
The role of type 4 phosphodiesterases in generating microdomains of cAMP: Large scale stochastic simulations
-
Oliveira RF, Terrin A, Di Benedetto G, Cannon RC, Koh W, et al. (2010) The role of type 4 phosphodiesterases in generating microdomains of cAMP: large scale stochastic simulations. PLoS One 5: e11725.
-
(2010)
PLoS One
, vol.5
-
-
Oliveira, R.F.1
Terrin, A.2
Di Benedetto, G.3
Cannon, R.C.4
Koh, W.5
-
7
-
-
0027203084
-
Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons
-
Frey U, Huang YY, Kandel ER (1993) Effects of cAMP simulate a late stage of LTP in hippocampal CA1 neurons. Science 260: 1661-1664. (Pubitemid 23247151)
-
(1993)
Science
, vol.260
, Issue.5114
, pp. 1661-1664
-
-
Frey, U.1
Huang, Y.-Y.2
Kandel, E.R.3
-
8
-
-
33846975147
-
Role of phosphodiesterases in neurological and psychiatric disease
-
DOI 10.1016/j.coph.2006.08.014, PII S1471489206001950, Neurosciences
-
Hebb AL, Robertson HA (2007) Role of phosphodiesterases in neurological and psychiatric disease. Curr Opin Pharmacol 7: 86-92. (Pubitemid 46242039)
-
(2007)
Current Opinion in Pharmacology
, vol.7
, Issue.1
, pp. 86-92
-
-
Hebb, A.L.1
Robertson, H.A.2
-
9
-
-
24944520099
-
Phosphodiesterase inhibitors for cognitive enhancement
-
DOI 10.2174/138161205774370799
-
Rose GM, Hopper A, De Vivo M, Tehim A (2005) Phosphodiesterase inhibitors for cognitive enhancement. Curr Pharm Des 11: 3329-3334. (Pubitemid 41300762)
-
(2005)
Current Pharmaceutical Design
, vol.11
, Issue.26
, pp. 3329-3334
-
-
Rose, G.M.1
Hopper, A.2
De Vivo, M.3
Tehim, A.4
-
10
-
-
84885472234
-
Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders
-
Sharma S, Kumar K, Deshmukh R, Sharma PL (2013) Phosphodiesterases: Regulators of cyclic nucleotide signals and novel molecular target for movement disorders. Eur J Pharmacol 714: 486-497.
-
(2013)
Eur J Pharmacol
, vol.714
, pp. 486-497
-
-
Sharma, S.1
Kumar, K.2
Deshmukh, R.3
Sharma, P.L.4
-
11
-
-
4344676386
-
cA glutamine switch mechanism for nucleotide selectivity by phosphodiesterases
-
DOI 10.1016/j.molcel.2004.07.005, PII S1097276504004083
-
Zhang KY, Card GL, Suzuki Y, Artis DR, Fong D, et al. (2004) A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases. Mol Cell 15: 279-286. (Pubitemid 38950974)
-
(2004)
Molecular Cell
, vol.15
, Issue.2
, pp. 279-286
-
-
Zhang, K.Y.J.1
Card, G.L.2
Suzuki, Y.3
Artis, D.R.4
Fong, D.5
Gillette, S.6
Hsieh, D.7
Neiman, J.8
West, B.L.9
Zhang, C.10
Milburn, M.V.11
Kim, S.-H.12
Schlessinger, J.13
Bollag, G.14
-
12
-
-
78650891913
-
Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling
-
Li YF, Cheng YF, Huang Y, Conti M, Wilson SP, et al. (2011) Phosphodiesterase-4D knock-out and RNA interference-mediated knock-down enhance memory and increase hippocampal neurogenesis via increased cAMP signaling. J Neurosci 31: 172-183.
-
(2011)
J Neurosci
, vol.31
, pp. 172-183
-
-
Li, Y.F.1
Cheng, Y.F.2
Huang, Y.3
Conti, M.4
Wilson, S.P.5
-
13
-
-
70349150027
-
Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus
-
Li YF, Huang Y, Amsdell SL, Xiao L, O'Donnell JM, et al. (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic AMP response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34: 2404-2419.
-
(2009)
Neuropsychopharmacology
, vol.34
, pp. 2404-2419
-
-
Li, Y.F.1
Huang, Y.2
Amsdell, S.L.3
Xiao, L.4
O'Donnell, J.M.5
-
14
-
-
85047694516
-
Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment
-
DOI 10.1172/JCI200422831
-
Gong B, Vitolo OV, Trinchese F, Liu S, Shelanski M, et al. (2004) Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment. J Clin Invest 114: 1624-1634. (Pubitemid 40385553)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.11
, pp. 1624-1634
-
-
Gong, B.1
Vitolo, O.V.2
Trinchese, F.3
Liu, S.4
Shelanski, M.5
Arancio, O.6
-
15
-
-
84902124631
-
Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D
-
Sierksma AS, van den Hove DL, Pfau F, Philippens M, Bruno O, et al. (2013) Improvement of spatial memory function in APPswe/PS1dE9 mice after chronic inhibition of phosphodiesterase type 4D. Neuropharmacology.
-
(2013)
Neuropharmacology
-
-
Sierksma, A.S.1
Van Den Hove, D.L.2
Pfau, F.3
Philippens, M.4
Bruno, O.5
-
16
-
-
79551554590
-
The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease
-
Munoz-Sanjuan I, Bates GP (2011) The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease. J Clin Invest 121: 476-483.
-
(2011)
J Clin Invest
, vol.121
, pp. 476-483
-
-
Munoz-Sanjuan, I.1
Bates, G.P.2
-
17
-
-
73749085726
-
Altered white matter microstructure in the corpus callosum in Huntington's disease: Implications for cortical "disconnection"
-
Rosas HD, Lee SY, Bender AC, Zaleta AK, Vangel M, et al. (2010) Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection". Neuroimage 49: 2995-3004.
-
(2010)
Neuroimage
, vol.49
, pp. 2995-3004
-
-
Rosas, H.D.1
Lee, S.Y.2
Bender, A.C.3
Zaleta, A.K.4
Vangel, M.5
-
18
-
-
79961208186
-
A tale of two factors: What determines the rate of progression in Huntington's disease? A longitudinal MRI study
-
Rosas HD, Reuter M, Doros G, Lee SY, Triggs T, et al. (2011) A tale of two factors: what determines the rate of progression in Huntington's disease? A longitudinal MRI study. Mov Disord 26: 1691-1697.
-
(2011)
Mov Disord
, vol.26
, pp. 1691-1697
-
-
Rosas, H.D.1
Reuter, M.2
Doros, G.3
Lee, S.Y.4
Triggs, T.5
-
19
-
-
83555173501
-
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: Analysis of 24 month observational data
-
Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, et al. (2012) Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Lancet Neurol 11: 42-53.
-
(2012)
Lancet Neurol
, vol.11
, pp. 42-53
-
-
Tabrizi, S.J.1
Reilmann, R.2
Roos, R.A.3
Durr, A.4
Leavitt, B.5
-
20
-
-
84876133677
-
Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy
-
Scahill RI, Hobbs NZ, Say MJ, Bechtel N, Henley SM, et al. (2011) Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy. Hum Brain Mapp.
-
(2011)
Hum Brain Mapp
-
-
Scahill, R.I.1
Hobbs, N.Z.2
Say, M.J.3
Bechtel, N.4
Henley, S.M.5
-
21
-
-
17144386565
-
cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues
-
Chiang MC, Lee YC, Huang CL, Chern Y (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J Biol Chem 280: 14331-14340.
-
(2005)
J Biol Chem
, vol.280
, pp. 14331-14340
-
-
Chiang, M.C.1
Lee, Y.C.2
Huang, C.L.3
Chern, Y.4
-
22
-
-
43649092175
-
Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease
-
DeMarch Z, Giampa C, Patassini S, Bernardi G, Fusco FR (2008) Beneficial effects of rolipram in the R6/2 mouse model of Huntington's disease. Neurobiol Dis 30: 375-387.
-
(2008)
Neurobiol Dis
, vol.30
, pp. 375-387
-
-
DeMarch, Z.1
Giampa, C.2
Patassini, S.3
Bernardi, G.4
Fusco, F.R.5
-
23
-
-
33846386124
-
Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity
-
DOI 10.1016/j.nbd.2006.09.006, PII S0969996106002361
-
DeMarch Z, Giampa C, Patassini S, Martorana A, Bernardi G, et al. (2007) Beneficial effects of rolipram in a quinolinic acid model of striatal excitotoxicity. Neurobiol Dis 25: 266-273. (Pubitemid 46127843)
-
(2007)
Neurobiology of Disease
, vol.25
, Issue.2
, pp. 266-273
-
-
DeMarch, Z.1
Giampa, C.2
Patassini, S.3
Martorana, A.4
Bernardi, G.5
Fusco, F.R.6
-
24
-
-
61449226493
-
Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease
-
Giampa C, Middei S, Patassini S, Borreca A, Marullo F, et al. (2009) Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease. Eur J Neurosci 29: 902-910.
-
(2009)
Eur J Neurosci
, vol.29
, pp. 902-910
-
-
Giampa, C.1
Middei, S.2
Patassini, S.3
Borreca, A.4
Marullo, F.5
-
25
-
-
67349165136
-
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease
-
Giampa C, Patassini S, Borreca A, Laurenti D, Marullo F, et al. (2009) Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease. Neurobiol Dis 34: 450-456.
-
(2009)
Neurobiol Dis
, vol.34
, pp. 450-456
-
-
Giampa, C.1
Patassini, S.2
Borreca, A.3
Laurenti, D.4
Marullo, F.5
-
26
-
-
0037335074
-
Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice
-
Gines S (2003) Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington's disease knock-in mice. Human Molecular Genetics 12: 497-508.
-
(2003)
Human Molecular Genetics
, vol.12
, pp. 497-508
-
-
Gines, S.1
-
27
-
-
78650779872
-
Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease
-
Kleiman RJ, Kimmel LH, Bove SE, Lanz TA, Harms JF, et al. (2011) Chronic suppression of phosphodiesterase 10A alters striatal expression of genes responsible for neurotransmitter synthesis, neurotransmission, and signaling pathways implicated in Huntington's disease. J Pharmacol Exp Ther 336: 64-76.
-
(2011)
J Pharmacol Exp Ther
, vol.336
, pp. 64-76
-
-
Kleiman, R.J.1
Kimmel, L.H.2
Bove, S.E.3
Lanz, T.A.4
Harms, J.F.5
-
28
-
-
0742287915
-
CRE-Mediated Transcription Is Increased in Huntington's Disease Transgenic Mice
-
DOI 10.1523/JNEUROSCI.3493-03.2004
-
Obrietan K, Hoyt KR (2004) CRE-mediated transcription is increased in Huntington's disease transgenic mice. J Neurosci 24: 791-796. (Pubitemid 38146589)
-
(2004)
Journal of Neuroscience
, vol.24
, Issue.4
, pp. 791-796
-
-
Obrietan, K.1
Hoyt, K.R.2
-
29
-
-
77951206413
-
Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF
-
Puerta E, Hervias I, Barros-Minones L, Jordan J, Ricobaraza A, et al. (2010) Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. Neurobiol Dis 38: 237-245.
-
(2010)
Neurobiol Dis
, vol.38
, pp. 237-245
-
-
Puerta, E.1
Hervias, I.2
Barros-Minones, L.3
Jordan, J.4
Ricobaraza, A.5
-
30
-
-
1042289730
-
Decreased cAMP response element-mediated transcription. An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis
-
DOI 10.1074/jbc.M310226200
-
Sugars KL, Brown R, Cook LJ, Swartz J, Rubinsztein DC (2004) Decreased cAMP response element-mediated transcription: an early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis. J Biol Chem 279: 4988-4999. (Pubitemid 38199095)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.6
, pp. 4988-4999
-
-
Sugars, K.L.1
Brown, R.2
Cook, L.J.3
Swartz, J.4
Rubinsztein, D.C.5
-
31
-
-
34147136044
-
CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease
-
DOI 10.1126/science.1139517
-
Jung J, Bonini N (2007) CREB-binding protein modulates repeat instability in a Drosophila model for polyQ disease. Science 315: 1857-1859. (Pubitemid 46580147)
-
(2007)
Science
, vol.315
, Issue.5820
, pp. 1857-1859
-
-
Jung, J.1
Bonini, N.2
-
32
-
-
0036578784
-
Disruption of CREB function in brain leads to neurodegeneration
-
Mantamadiotis T, Lemberger T, Bleckmann SC, Kern H, Kretz O, et al. (2002) Disruption of CREB function in brain leads to neurodegeneration. Nat Genet 31: 47-54.
-
(2002)
Nat Genet
, vol.31
, pp. 47-54
-
-
Mantamadiotis, T.1
Lemberger, T.2
Bleckmann, S.C.3
Kern, H.4
Kretz, O.5
-
33
-
-
59449106602
-
Selective phosphodiesterase inhibitors: A promising target for cognition enhancement
-
Reneerkens O, Rutten K, Steinbusch H, Blokland A, Prickaerts J (2009) Selective phosphodiesterase inhibitors: a promising target for cognition enhancement. Psychopharmacology 202: 419-443.
-
(2009)
Psychopharmacology
, vol.202
, pp. 419-443
-
-
Reneerkens, O.1
Rutten, K.2
Steinbusch, H.3
Blokland, A.4
Prickaerts, J.5
-
34
-
-
0027314157
-
Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain
-
DOI 10.1016/0167-4943(93)90009-7
-
Asanuma M, Ogawa N, Kondo Y, Hirata H, Mori A (1993) Effects of repeated administration of rolipram, a cAMP-specific phosphodiesterase inhibitor, on acetylcholinergic indices in the aged rat brain. Arch Gerontol Geriatr 16: 191-198. (Pubitemid 23196747)
-
(1993)
Archives of Gerontology and Geriatrics
, vol.16
, Issue.2
, pp. 191-198
-
-
Asanuma, M.1
Ogawa, N.2
Kondo, Y.3
Hirata, H.4
Mori, A.5
-
35
-
-
48149108931
-
Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs
-
Bateup HS, Svenningsson P, Kuroiwa M, Gong S, Nishi A, et al. (2008) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11: 932-939.
-
(2008)
Nat Neurosci
, vol.11
, pp. 932-939
-
-
Bateup, H.S.1
Svenningsson, P.2
Kuroiwa, M.3
Gong, S.4
Nishi, A.5
-
36
-
-
74049158987
-
Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety
-
Burgin AB, Magnusson OT, Singh J, Witte P, Staker BL, et al. (2010) Design of phosphodiesterase 4D (PDE4D) allosteric modulators for enhancing cognition with improved safety. Nat Biotechnol 28: 63-70.
-
(2010)
Nat Biotechnol
, vol.28
, pp. 63-70
-
-
Burgin, A.B.1
Magnusson, O.T.2
Singh, J.3
Witte, P.4
Staker, B.L.5
-
37
-
-
27344449614
-
Keynote review: Phosphodiesterase-4 as a therapeutic target
-
DOI 10.1016/S1359-6446(05)03622-6, PII S1359644605036226
-
Houslay MD, Schafer P, Zhang KYJ (2005) Keynote review: Phosphodiesterase-4 as a therapeutic target. Drug Discovery Today 10: 1503-1519. (Pubitemid 41527193)
-
(2005)
Drug Discovery Today
, vol.10
, Issue.22
, pp. 1503-1519
-
-
Houslay, M.D.1
Schafer, P.2
Zhang, K.Y.J.3
-
38
-
-
34247603063
-
L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition
-
DOI 10.1016/j.bcp.2007.03.010, PII S0006295207001505
-
Huang Z, Dias R, Jones T, Liu S, Styhler A, et al. (2007) L-454,560, a potent and selective PDE4 inhibitor with in vivo efficacy in animal models of asthma and cognition. Biochem Pharmacol 73: 1971-1981. (Pubitemid 46677904)
-
(2007)
Biochemical Pharmacology
, vol.73
, Issue.12
, pp. 1971-1981
-
-
Huang, Z.1
Dias, R.2
Jones, T.3
Liu, S.4
Styhler, A.5
Claveau, D.6
Otu, F.7
Ng, K.8
Laliberte, F.9
Zhang, L.10
Goetghebeur, P.11
Abraham, W.M.12
Macdonald, D.13
Dube, D.14
Gallant, M.15
Lacombe, P.16
Girard, Y.17
Young, R.N.18
Turner, M.J.19
Nicholson, D.W.20
Mancini, J.A.21
more..
-
39
-
-
84873095711
-
Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex
-
Kuroiwa M, Snyder GL, Shuto T, Fukuda A, Yanagawa Y, et al. (2011) Phosphodiesterase 4 inhibition enhances the dopamine D1 receptor/PKA/DARPP-32 signaling cascade in frontal cortex. Psychopharmacology (Berl).
-
(2011)
Psychopharmacology (Berl)
-
-
Kuroiwa, M.1
Snyder, G.L.2
Shuto, T.3
Fukuda, A.4
Yanagawa, Y.5
-
40
-
-
84904696602
-
Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
-
Rodefer JS, Saland SK, Eckrich SJ (2011) Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats. Neuropharmacology.
-
(2011)
Neuropharmacology
-
-
Rodefer, J.S.1
Saland, S.K.2
Eckrich, S.J.3
-
41
-
-
43049118254
-
Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques
-
Rutten K, Basile JL, Prickaerts J, Blokland A, Vivian JA (2008) Selective PDE inhibitors rolipram and sildenafil improve object retrieval performance in adult cynomolgus macaques. Psychopharmacology (Berl) 196: 643-648.
-
(2008)
Psychopharmacology (Berl)
, vol.196
, pp. 643-648
-
-
Rutten, K.1
Basile, J.L.2
Prickaerts, J.3
Blokland, A.4
Vivian, J.A.5
-
42
-
-
57049135076
-
In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats
-
Marte A, Pepicelli O, Cavallero A, Raiteri M, Fedele E (2008) In vivo effects of phosphodiesterase inhibition on basal cyclic guanosine monophosphate levels in the prefrontal cortex, hippocampus and cerebellum of freely moving rats. J Neurosci Res 86: 3338-3347.
-
(2008)
J Neurosci Res
, vol.86
, pp. 3338-3347
-
-
Marte, A.1
Pepicelli, O.2
Cavallero, A.3
Raiteri, M.4
Fedele, E.5
-
43
-
-
34547839797
-
Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage
-
DOI 10.1093/hmg/ddm133
-
Kuhn A, Goldstein DR, Hodges A, Strand AD, Sengstag T, et al. (2007) Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum Mol Genet 16: 1845-1861. (Pubitemid 47244533)
-
(2007)
Human Molecular Genetics
, vol.16
, Issue.15
, pp. 1845-1861
-
-
Kuhn, A.1
Goldstein, D.R.2
Hodges, A.3
Strand, A.D.4
Sengstag, T.5
Kooperberg, C.6
Becanovic, K.7
Pouladi, M.A.8
Sathasivam, K.9
Cha, J.-H.J.10
Hannan, A.J.11
Hayden, M.R.12
Leavitt, B.R.13
Dunnett, S.B.14
Ferrante, R.J.15
Albin, R.16
Shelbourne, P.17
Delorenzi, M.18
Augood, S.J.19
Faull, R.L.M.20
Olson, J.M.21
Bates, G.P.22
Jones, L.23
Luthi-Carter, R.24
more..
-
44
-
-
62449195496
-
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation
-
Threlfell S, Sammut S, Menniti FS, Schmidt CJ, West AR (2009) Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation. J Pharmacol Exp Ther 328: 785-795.
-
(2009)
J Pharmacol Exp Ther
, vol.328
, pp. 785-795
-
-
Threlfell, S.1
Sammut, S.2
Menniti, F.S.3
Schmidt, C.J.4
West, A.R.5
-
45
-
-
34247596903
-
The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat
-
DOI 10.1007/s00213-006-0697-4
-
Rutten K, Lieben C, Smits L, Blokland A (2007) The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology (Berl) 192: 275-282. (Pubitemid 46669202)
-
(2007)
Psychopharmacology
, vol.192
, Issue.2
, pp. 275-282
-
-
Rutten, K.1
Lieben, C.2
Smits, L.3
Blokland, A.4
-
46
-
-
32644461812
-
Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action
-
DOI 10.1016/j.nlm.2005.09.002, PII S1074742705000869
-
Rutten K, Prickaerts J, Blokland A (2006) Rolipram reverses scopolamine-induced and time-dependent memory deficits in object recognition by different mechanisms of action. Neurobiol Learn Mem 85: 132-138. (Pubitemid 43247839)
-
(2006)
Neurobiology of Learning and Memory
, vol.85
, Issue.2
, pp. 132-138
-
-
Rutten, K.1
Prickaerts, J.2
Blokland, A.3
-
47
-
-
0031048406
-
Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents
-
DOI 10.1016/S0014-2999(96)00969-7, PII S0014299996009697
-
Imanishi T, Sawa A, Ichimaru Y, Miyashiro M, Kato S, et al. (1997) Ameliorating effects of rolipram on experimentally induced impairments of learning and memory in rodents. Eur J Pharmacol 321: 273-278. (Pubitemid 27105928)
-
(1997)
European Journal of Pharmacology
, vol.321
, Issue.3
, pp. 273-278
-
-
Imanishi, T.1
Sawa, A.2
Ichimaru, Y.3
Miyashiro, M.4
Kato, S.5
Yamamoto, T.6
Ueki, S.7
-
48
-
-
0024045691
-
Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: A double-blind double-dummy study aimed at testing a novel therapeutic approach
-
Bertolino A, Crippa D, di Dio S, Fichte K, Musmeci G, et al. (1988) Rolipram versus imipramine in inpatients with major, "minor" or atypical depressive disorder: a double-blind double-dummy study aimed at testing a novel therapeutic approach. Int Clin Psychopharmacol 3: 245-253.
-
(1988)
Int Clin Psychopharmacol
, vol.3
, pp. 245-253
-
-
Bertolino, A.1
Crippa, D.2
Di Dio, S.3
Fichte, K.4
Musmeci, G.5
-
49
-
-
0024319477
-
Rolipram in major depressive disorder: Results of double-blind comparative study with imipramine
-
Hebenstreit GF, Fellerer K, Fichte K, Fischer G, Geyer N, et al. (1989) Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine. Pharmacopsychiatry 22: 156-160. (Pubitemid 19176094)
-
(1989)
Pharmacopsychiatry
, vol.22
, Issue.4
, pp. 156-160
-
-
Hebenstreit, G.F.1
Fellerer, K.2
Fichte, K.3
Fischer, G.4
Geyer, N.5
Meya, U.6
Sastre-Y-Hernandez, M.7
Schony, W.8
Schratzer, M.9
Soukop, W.10
Trampitsch, E.11
Varosanec, S.12
Zawada, E.13
Zochling, R.14
-
50
-
-
36749000152
-
Structures of the four subfamilies of phosphodiesterases provide insight into the selectivity of their inhibitors
-
DOI 10.1042/BJ20070970
-
Wang H, Peng MS, Chen Y, Geng J, Robinson H, et al. (2007) Structures of the four subfamilies of phosphodiesterase-4 provide insight into the selectivity of their inhibitors. Biochem J 408: 193-201. (Pubitemid 350206342)
-
(2007)
Biochemical Journal
, vol.408
, Issue.2
, pp. 193-201
-
-
Wang, H.1
Peng, M.-S.2
Chen, Y.3
Geng, J.4
Robinson, H.5
Houslay, M.D.6
Cai, J.7
Ke, H.8
-
51
-
-
81455151817
-
GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses
-
Bruno O, Fedele E, Prickaerts J, Parker LA, Canepa E, et al. (2011) GEBR-7b, a novel PDE4D selective inhibitor that improves memory in rodents at non-emetic doses. Br J Pharmacol 164: 2054-2063.
-
(2011)
Br J Pharmacol
, vol.164
, pp. 2054-2063
-
-
Bruno, O.1
Fedele, E.2
Prickaerts, J.3
Parker, L.A.4
Canepa, E.5
-
52
-
-
79955803729
-
ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity
-
Kobayashi M, Kubo S, Iwata M, Ohtsu Y, Takahashi K, et al. (2011) ASP3258, an orally active potent phosphodiesterase 4 inhibitor with low emetic activity. Int Immunopharmacol 11: 732-739.
-
(2011)
Int Immunopharmacol
, vol.11
, pp. 732-739
-
-
Kobayashi, M.1
Kubo, S.2
Iwata, M.3
Ohtsu, Y.4
Takahashi, K.5
-
53
-
-
0036152721
-
Assessing the emetic potential of PDE4 inhibitors in rats
-
Robichaud A, Savoie C, Stamatiou PB, Lachance N, Jolicoeur P, et al. (2002) Assessing the emetic potential of PDE4 inhibitors in rats. Br J Pharmacol 135: 113-118. (Pubitemid 34102104)
-
(2002)
British Journal of Pharmacology
, vol.135
, Issue.1
, pp. 113-118
-
-
Robichaud, A.1
Savoie, C.2
Stamatiou, P.B.3
Lachance, N.4
Jolicoeur, P.5
Rasori, R.6
Chan, C.C.7
-
54
-
-
0033043309
-
Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret
-
DOI 10.1016/S0028-3908(98)00190-7, PII S0028390898001907
-
Robichaud A, Tattersall FD, Choudhury I, Rodger IW (1999) Emesis induced by inhibitors of type IV cyclic nucleotide phosphodiesterase (PDE IV) in the ferret. Neuropharmacology 38: 289-297. (Pubitemid 29073550)
-
(1999)
Neuropharmacology
, vol.38
, Issue.2
, pp. 289-297
-
-
Robichaud, A.1
Tattersall, F.D.2
Choudhury, I.3
Rodger, I.W.4
-
55
-
-
0024380592
-
Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants
-
DOI 10.1037/0735-7044.103.3.526
-
Diamond A, Zola-Morgan S, Squire LR (1989) Successful performance by monkeys with lesions of the hippocampal formation on AB and object retrieval, two tasks that mark developmental changes in human infants. Behav Neurosci 103: 526-537. (Pubitemid 19161166)
-
(1989)
Behavioral Neuroscience
, vol.103
, Issue.3
, pp. 526-537
-
-
Diamond, A.1
Zola-Morgan, S.2
Squire, L.R.3
-
56
-
-
0030001887
-
Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease
-
Palfi S, Ferrante RJ, Brouillet E, Beal MF, Dolan R, et al. (1996) Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neurosci 16: 3019-3025. (Pubitemid 26121844)
-
(1996)
Journal of Neuroscience
, vol.16
, Issue.9
, pp. 3019-3025
-
-
Palfi, S.1
Ferrante, R.J.2
Brouillet, E.3
Beal, M.F.4
Dolan, R.5
Guyot, M.C.6
Peschanski, M.7
Hantraye, P.8
-
57
-
-
0029858598
-
Primate analogue of the Wisconsin Card Sorting Test: Effects of excitotoxic lesions of the prefrontal cortex in the marmoset
-
DOI 10.1037/0735-7044.110.5.872
-
Dias R, Robbins TW, Roberts AC (1996) Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 110: 872-886. (Pubitemid 26365787)
-
(1996)
Behavioral Neuroscience
, vol.110
, Issue.5
, pp. 872-886
-
-
Dias, R.1
Robbins, T.W.2
Roberts, A.C.3
-
58
-
-
0034114762
-
Inhibitory control and affective processing in the prefrontal cortex: Neuropsychological studies in the common marmoset
-
Roberts AC, Wallis JD (2000) Inhibitory Control and Affective Processing in the Prefrontal Cortex: Neuropsychological Studies in the Common Marmoset. Cerebral Cortex 10: 252-262. (Pubitemid 30159292)
-
(2000)
Cerebral Cortex
, vol.10
, Issue.3
, pp. 252-262
-
-
Roberts, A.C.1
Wallis, J.D.2
-
59
-
-
0036365967
-
Behavioral and Morphological Comparison of Two Nonhuman Primate Models of Huntington's Disease
-
Roitberg BZ, Emborg ME, Sramek JG, Palfi S, Kordower JH (2002) Behavioral and Morphological Comparison of Two Nonhuman Primate Models of Huntington's Disease. Neurosurgery 50: 137-146.
-
(2002)
Neurosurgery
, vol.50
, pp. 137-146
-
-
Roitberg, B.Z.1
Emborg, M.E.2
Sramek, J.G.3
Palfi, S.4
Kordower, J.H.5
-
60
-
-
33846238593
-
Impaired performance on the object retrieval-detour test of executive function in the SIV/macaque model of AIDS
-
DOI 10.1089/aid.2006.22.1031
-
Gray RA, Wilcox KM, Zink MC, Weed MR (2006) Impaired performance on the object retrieval-detour test of executive function in the SIV/macaque model of AIDS. AIDS Res Hum Retroviruses 22: 1031-1035. (Pubitemid 46100689)
-
(2006)
AIDS Research and Human Retroviruses
, vol.22
, Issue.10
, pp. 1031-1035
-
-
Gray, R.A.1
Wilcox, K.M.2
Zink, M.C.3
Weed, M.R.4
-
61
-
-
0025293227
-
Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys
-
Taylor JR, Elsworth JD, Roth RH, Sladek JR Jr, Redmond DE Jr (1990) Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain 113 (Pt 3): 617-637. (Pubitemid 20222322)
-
(1990)
Brain
, vol.113
, Issue.3
, pp. 617-637
-
-
Taylor, J.R.1
Elsworth, J.D.2
Roth, R.H.3
Sladek Jr., J.R.4
Redmond Jr., D.E.5
-
62
-
-
33745059015
-
Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task
-
DOI 10.1111/j.1460-9568.2006.04826.x
-
Walker SC, Mikheenko YP, Argyle LD, Robbins TW, Roberts AC (2006) Selective prefrontal serotonin depletion impairs acquisition of a detour-reaching task. Eur J Neurosci 23: 3119-3123. (Pubitemid 43882892)
-
(2006)
European Journal of Neuroscience
, vol.23
, Issue.11
, pp. 3119-3123
-
-
Walker, S.C.1
Mikheenko, Y.P.2
Argyle, L.D.3
Robbins, T.W.4
Roberts, A.C.5
-
63
-
-
0030862672
-
Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine
-
DOI 10.1126/science.277.5328.953
-
Jentsch JD, Redmond DE, Elsworth JD, Taylor JR, Youngren KD, et al. (1997) Enduring Cognitive Deficits and Cortical Dopamine Dysfunction in Monkeys After Long-Term Administration of Phencyclidine. Science 277: 953-955. (Pubitemid 27366680)
-
(1997)
Science
, vol.277
, Issue.5328
, pp. 953-955
-
-
Jentsch, J.D.1
Redmond Jr., D.E.2
Elsworth, J.D.3
Taylor, J.R.4
Youngren, K.D.5
Roth, R.H.6
-
64
-
-
0032587235
-
4 receptor antagonist reversal of subchronic phencyclidine- induced object retrieval/detour deficits in monkeys
-
DOI 10.1007/s002130050865
-
Jentsch JD, Taylor JR, Redmond DE Jr, Elsworth JD, Youngren KD, et al. (1999) Dopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys. Psychopharmacology (Berl) 142: 78-84. (Pubitemid 29196067)
-
(1999)
Psychopharmacology
, vol.142
, Issue.1
, pp. 78-84
-
-
Jentsch, J.D.1
Taylor, J.R.2
Redmond Jr., D.E.3
Elsworth, J.D.4
Youngren, K.D.5
Roth, R.H.6
-
65
-
-
84904661541
-
-
San Diego, USA
-
Tinsley M, Basile JL, Van-Natta K, Yeo H, Lowe DA, et al. (2007) Cognition enhancing effects of nicotinic acetylcholine alpha-7 receptor agonists in prefrontal cortex mediated tasks in adult monkeys; San Diego, USA.
-
(2007)
Cognition Enhancing Effects of Nicotinic Acetylcholine Alpha-7 Receptor Agonists in Prefrontal Cortex Mediated Tasks in Adult Monkeys
-
-
Tinsley, M.1
Basile, J.L.2
Van-Natta, K.3
Yeo, H.4
Lowe, D.A.5
-
66
-
-
59449106007
-
RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors
-
Ballard TM, Knoflach F, Prinssen E, Borroni E, Vivian JA, et al. (2009) RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors. Psychopharmacology (Berl) 202: 207-223.
-
(2009)
Psychopharmacology (Berl)
, vol.202
, pp. 207-223
-
-
Ballard, T.M.1
Knoflach, F.2
Prinssen, E.3
Borroni, E.4
Vivian, J.A.5
-
67
-
-
0242460552
-
Dysregulation of protein kinase A signaling in the aged prefrontal cortex: New strategy for treating age-related cognitive decline
-
DOI 10.1016/S0896-6273(03)00694-9
-
Ramos BP, Birnbaum SG, Lindenmayer I, Newton SS, Duman RS, et al. (2003) Dysregulation of protein kinase a signaling in the aged prefrontal cortex: new strategy for treating age-related cognitive decline. Neuron 40: 835-845. (Pubitemid 37431042)
-
(2003)
Neuron
, vol.40
, Issue.4
, pp. 835-845
-
-
Ramos, B.P.1
Birnbaum, S.G.2
Lindenmayer, I.3
Newton, S.S.4
Duman, R.S.5
Arnsten, A.F.T.6
-
68
-
-
0035134037
-
A good practice guide to the administration of substances and removal of blood, including routes and volumes
-
Diehl KH, Hull R, Morton D, Pfister R, Rabemampianina Y, et al. (2001) A good practice guide to the administration of substances and removal of blood, including routes and volumes. J Appl Toxicol 21: 15-23.
-
(2001)
J Appl Toxicol
, vol.21
, pp. 15-23
-
-
Diehl, K.H.1
Hull, R.2
Morton, D.3
Pfister, R.4
Rabemampianina, Y.5
-
69
-
-
70350054854
-
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids
-
Friden M, Winiwarter S, Jerndal G, Bengtsson O, Wan H, et al. (2009) Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids. J Med Chem 52: 6233-6243.
-
(2009)
J Med Chem
, vol.52
, pp. 6233-6243
-
-
Friden, M.1
Winiwarter, S.2
Jerndal, G.3
Bengtsson, O.4
Wan, H.5
-
70
-
-
78649706279
-
The effect of plasma protein binding on in vivo efficacy: Misconceptions in drug discovery
-
Smith DA, Di L, Kerns EH (2010) The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery. Nat Rev Drug Discov 9: 929-939.
-
(2010)
Nat Rev Drug Discov
, vol.9
, pp. 929-939
-
-
Smith, D.A.1
Di, L.2
Kerns, E.H.3
-
71
-
-
84872319925
-
Demystifying brain penetration in central nervous system drug discovery. Miniperspective
-
Di L, Rong H, Feng B (2013) Demystifying brain penetration in central nervous system drug discovery. Miniperspective. J Med Chem 56: 2-12.
-
(2013)
J Med Chem
, vol.56
, pp. 2-12
-
-
Di, L.1
Rong, H.2
Feng, B.3
-
72
-
-
0036790480
-
Deletion of phosphodiesterase 4D in mice shortens alpha2-adrenoceptor- mediated anesthesia, a behavioral correlate of emesis
-
Robichaud A (2002) Deletion of phosphodiesterase 4D in mice shortens alpha2-adrenoceptor-mediated anesthesia, a behavioral correlate of emesis. Journal of Clinical Investigation 110: 1045-1052.
-
(2002)
Journal of Clinical Investigation
, vol.110
, pp. 1045-1052
-
-
Robichaud, A.1
|